Caspase inhibitors improve survival in sepsis: A critical role of the lymphocyte

Nature Immunology

Volumn 1, Issue 6, 2000, Pages 496-501

  Hotchkiss, R S ^a   Chang, K C ^a   Swanson, P E ^a   Tinsley, K W ^a   Hui, J J ^a   Klender, P ^a   Xanthoudakis, S ^b   Roy, S ^b   Black, C ^b   Grimm, E ^b   Aspiotis, R ^b   Han, Y ^b   Nicholson, D W ^b   Karl, I E ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MERCK FROSST CENTRE FOR THERAPEUTIC RESEARCH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CASP3 PROTEIN, HUMAN; CASP3 PROTEIN, MOUSE; CASPASE; CASPASE 3; CYSTEINE PROTEINASE INHIBITOR; GAMMA INTERFERON; HOMEODOMAIN PROTEIN; INTERLEUKIN 2; RAG 1 PROTEIN; RAG-1 PROTEIN;

ADOPTIVE TRANSFER; ANIMAL; APOPTOSIS; ARTICLE; BACTEREMIA; BACTERIAL COUNT; BIOSYNTHESIS; DRUG ANTAGONISM; DRUG EFFECT; FEMALE; GENETICS; HUMAN; IN VITRO STUDY; LYMPHOCYTE; METABOLISM; MICROBIOLOGY; MOUSE; MOUSE MUTANT; PATHOLOGY; SEPSIS;

ADOPTIVE TRANSFER; ANIMALS; APOPTOSIS; BACTEREMIA; CASPASE 3; CASPASES; COLONY COUNT, MICROBIAL; CYSTEINE PROTEINASE INHIBITORS; FEMALE; HOMEODOMAIN PROTEINS; HUMANS; INTERFERON TYPE II; INTERLEUKIN-2; LYMPHOCYTES; MICE; MICE, KNOCKOUT; SEPSIS;

EID: 5944251623     PISSN: 15292908     EISSN: None     Source Type: Journal    
DOI: 10.1038/82741     Document Type: Article

References (33)

1. Wang, S. D., Huang, K. J., Lin, Y. S. & Lei, H. Y. Sepsis-induced apoptosis of the thymocytes in mice. J. Immunol. 152, 5014-5021 (1994).
2. Ayala, A., Herndon, C., Lehman, D. & Chaudry, I. H. Differential induction of apoptosis in lymphoid tissue during sepsis: variation in onset, frequency and nature of the mediators. Blood 87, 4261-4275 (1996).
3. Hotchkiss, R. S. et al. Apoptosis in lymphoid and parenchymal cells during sepsis: Findings in normal and T- and B-cell deficient mice. Crit. Care Med. 25, 1298-1307 (1997).
4. Hotchkiss, R. S. et al. Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction. Crit. Care Med. 27,1230-1251 (1999).
5. Thornberry, N.A. & Lazebnik, Y. Caspases: enemies within. Science 281, 1312-1316 (1998).
6. Nicholson, D.W. Caspase structure, proteolytic substrates, and function during apoptotic cell death. Cell Death Differ. 6, 1028-1042 (1999).
7. Endres, M. et al. Attenuation of delayed neuronal death after mild focal ischemia in mice by inhibition of the caspase family. J. Cere. Blood Flow Metabol. 18, 238-247 (1988).
8. Fukuzuka, K. et al. Caspase-3-dependent organ apoptosis early after burn injury. Ann. Surg. 229, 851-858 (1999).
9. Grobmeyer, S. R. et al. Peptidomimetic fluoromethylketone rescues mice from lethal endotoxic shock. Mol. Med. 5, 585-594 (1999).
10. Hotchkiss, R. S. et al. Prevention of lymphocyte cell death in sepsis improves survival in mice. Proc. Natl Acad, Sci. USA 96,14541-14546 (1999).
11. Varfolomeev, E. E. et al. Targeted disruption of the mouse caspase 8 gene ablates cell death induction by the TNF receptors, Fas/ApoI and DR3 and is lethal prenatally. Immunity 9, 267-276 (1998).
12. Kuida, K. et al. Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase 9. Cell 94, 325-337 (1998).
13. Hakem, R. et al. Differential requirement for caspase 9 in apoptotic pathways in vivo. Cell 94, 339-352 (1998).
14. Zheng, T. S., Hunot, S., Kuida, K. & Flavell, R. A. Caspase knockouts: matters of life and death. Cell Death Differ. 6,1043-1053 (1999).
15. Kuida, K et al. Decrease apoptosis in the brain and premature lethality in CPP32-deficient mice. Nature 384, 368-372 (1996).
16. Woo, M. et al. Essential contribution of caspase 3/CPP32 to apoptosis and its associated nuclear changes. Genes Dev. 12, 806-819 (1998).
17. Garcia-Calvo, M. et al. Inhibition of human caspases by peptide-based and macromolecular inhibitors. J. Biol. Chem. 273, 32608-32613 (1998).
18. Baker, C. C., Chaudry, I. H., Gains, H. O. & Baue, A. E. Evaluation of factors affecting mortality rate after sepsis in a murine cecal ligation and puncture mode. Surgery 94, 331-335 (1983).
19. Remick, D. G., Newcomb, D. E., Bolgos, G. L. & Call, D. R. Comparison of the mortality and inflammatory response of two models of sepsis: lipopolysaccharide versus cecal ligation and puncture. Shock 13, 110-116 (2000).
20. Hotchkiss, R. S. et al. Overexpression of Bcl-2 in transgenic mice decreases apoptosis and improves survival in sepsis. J. Immunol. 162, 4148-4156 (1999).
21. 18F]fluoromisonidazole. Am. J. Physiol. 30, 965-972 (1991).
22. Janicke, R. U., Sprengart, M. L., Wati, M. R. & Porter, A. G. Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis. J. Biol. Chem. 273, 9357-9360 (1998).
23. Medzhitov, R., Janeway, C. Innate immunity. N. Engl. J. Med. 343, 338-344 (2000).
24. Abbas, A. K., Lichtman, A. H. & Pober, J. S. in Cellular and Molecular Immunology 4th edn, 4 (W. B. Saunders Co., Philadelphia, 2000).
25. Janeway, C.A., Travers, P., Walport, M. & Capra, J. D. in Immunobiology: The immune system in health and disease 4th edn, 219 (Current Biology Publications, London, 1999).
26. Braun, J. S. et al. Neuroprotection by a caspase inhibitor in acute bacterial meningitis. Nature Med. 5, 298-302. (1999).
27. Oberholzer, A., Oberholzer, C. & Moldawer, L. L. Cytokine signaling- regulation of the immune system in normal and critically ill states. Crit Care Med. 28, 53 (2000).
28. Yagupsky, P. & Notte, F. S. Quantitative aspects of septicemia. Clin. Microbiol. Rev. 3, 269-279 (1990)
29. Bell, L. M., Alpert, G., Campos, J. M. & Plotkin, S.A. Routine quantitative blood cultures in children with Haemophilus influenzae or Streptococcus pneumoniae bacteremia. Pediatrics 76, 901-904 (1985).
30. Goronzy, J., Weyand, C., Quan, J., Fathman, C. G. & O'Hanley, P. Enhanced cell-mediated protection against fatal Escherichia coli septicemia induced by treatment with recombinant IL-2. J. Immunol. 142, 1134-1138 (1989).
31. Docke, W. E. et al. Monocyte deactivation in septic patients: restoration by IFN-γ treatment. Nature Med. 3, 678-681 (1997).
32. Garcia-Calvo, et al. Inhibition of human caspases by peptide-based and macromolecular inhibitors. J. Biol. Chem. 273, 32608-32613 (1998).
33. Garcia-Calvo, M. et al. Purification and catalytic properties of human caspase family members. Cell Death Differ 6, 362-369 (1999).